FACULTY
|
PROF ANNE SCHILDER
Professor of Otorhinolaryngology BRC University College London United Kingdom |
Anne Schilder, Commissioner
Anne Schilder is Professor of Otorhinolaryngology at the University College London Ear Institute and Director of the National Institute for Health Research UCLH Biomedical Research Centre Hearing Theme. She practices Pediatric ENT at the Royal National Throat, Nose and Ear Hospital, London. As joint Co-ordinating Editor of Cochrane ENT, NIHR Clinical Research Network Specialty Lead for ENT and Surgical Specialty Lead for ENT of Royal College of Surgeon’s England, her current research focuses on hearing loss, a condition that affects one in six people in the UK and has a major impact on their physical, mental and social health.
Hearing loss acquired in mid-life has recently been identified as a significant risk factor for dementia. Based on recent discoveries in the mechanisms of hearing loss, and supported by major public and private funds, a range of novel drug, gene and cell therapies are being developed to protect, restore and regenerate the hearing system. Anne’s research focuses on the translational aspects of applying these innovative hearing approaches in existing healthcare systems, and ranges from first-in-man trials, analysis of routine health data, to health economics and health policy.
She also holds a chair at the University Medical Center Utrecht in the Netherlands, working with primary care researchers on developing evidence based interventions for otitis media in children. She is a Visiting Professor at Oxford University and Macquarie University, Sydney, Australia.
Anne Schilder is Professor of Otorhinolaryngology at the University College London Ear Institute and Director of the National Institute for Health Research UCLH Biomedical Research Centre Hearing Theme. She practices Pediatric ENT at the Royal National Throat, Nose and Ear Hospital, London. As joint Co-ordinating Editor of Cochrane ENT, NIHR Clinical Research Network Specialty Lead for ENT and Surgical Specialty Lead for ENT of Royal College of Surgeon’s England, her current research focuses on hearing loss, a condition that affects one in six people in the UK and has a major impact on their physical, mental and social health.
Hearing loss acquired in mid-life has recently been identified as a significant risk factor for dementia. Based on recent discoveries in the mechanisms of hearing loss, and supported by major public and private funds, a range of novel drug, gene and cell therapies are being developed to protect, restore and regenerate the hearing system. Anne’s research focuses on the translational aspects of applying these innovative hearing approaches in existing healthcare systems, and ranges from first-in-man trials, analysis of routine health data, to health economics and health policy.
She also holds a chair at the University Medical Center Utrecht in the Netherlands, working with primary care researchers on developing evidence based interventions for otitis media in children. She is a Visiting Professor at Oxford University and Macquarie University, Sydney, Australia.
